Q3 2015 Holdings
Filed 2015-11-13 | 88 holdings | $21.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atricure Inc(ATRC) | COM | 04963C209 | $10.7M | 487,946 | 49.6% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $6.3M | 116,581 | 29.4% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $2.9M | 258,642 | 13.7% |
| Ascendis Pharma(ASND) | ADR | 04351P101 | $942.0K | 53,241 | 4.4% |
| Caredx Inc(CDNA) | COM | 14167L103 | $567.0K | 135,927 | 2.6% |
| Nxstage Medical Inc | COM | 67072V103 | $5.8K | 366,554 | 0.0% |
| ZS Pharma Inc | COM | 98979G105 | $4.3K | 66,194 | 0.0% |
| Achillion Pharmaceuticals(ACHNEUR) | COM | 00448Q201 | $3.3K | 480,300 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $2.9K | 165,669 | 0.0% |
| Biotelemetry Inc(BEATEUR) | COM | 090672106 | $2.9K | 235,645 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $2.7K | 106,018 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $2.7K | 1,109,740 | 0.0% |
| Protalix Biotherapeutics Inc | NOTE 4.500% 9/1 | 74365AAB7 | $2.7K | $4,000,000 | 0.0% |
| Discovery Laboratories Inc | COM NEW | 254668403 | $2.3K | 7,508,544 | 0.0% |
| Insulet Corp | NOTE 2.000% 6/1 | 45784PAD3 | $2.2K | $2,407,000 | 0.0% |
| Applied Genetic Technol Corp(2GT) | COM | 03820J100 | $2.1K | 157,192 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $2.0K | 111,466 | 0.0% |
| Masimo Corporation(MASI) | COM | 574795100 | $1.8K | 46,010 | 0.0% |
| Derma Sciences Inc | COM PAR $.01 | 249827502 | $1.7K | 356,918 | 0.0% |
| Xenoport Inc | COM | 98411C100 | $1.6K | 470,612 | 0.0% |
| Synergy Pharmaceuticals | COM | 871639308 | $1.6K | 296,563 | 0.0% |
| Essa Pharma Inc | COM | 29668H104 | $1.4K | 228,500 | 0.0% |
| Protalix Biotherapeutics Inc | COM | 74365A101 | $1.4K | 1,193,189 | 0.0% |
| Cytrx Corp | COM PAR $.001 | 232828509 | $1.4K | 583,013 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $1.3K | 93,574 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM ADDED | 64052L106 | $1.3K | 63,400 | 0.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $1.3K | 1,372,862 | 0.0% |
| Celyad | ADR | 151205200 | $1.3K | 30,000 | 0.0% |
| Avalanche Biotechnologies in | COM | 05337G107 | $1.2K | 140,600 | 0.0% |
| Scynexis Inc | COM | 811292101 | $1.1K | 156,904 | 0.0% |
| Novadaq Technologies Inc | COM | 66987G102 | $1.1K | 101,841 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $1.0K | 123,500 | 0.0% |
| Nuvasive Inc | NOTE 2.750% 7/0 | 670704AC9 | $959 | $760,000 | 0.0% |
| Spectranetics Corp | COM | 84760C107 | $941 | 79,812 | 0.0% |
| Zogenix Inc | COM | 98978L204 | $930 | 68,900 | 0.0% |
| Johnson and Johnson(JNJ) | COM | 478160104 | $877 | 9,400 | 0.0% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $780 | 70,885 | 0.0% |
| Intec Pharma LTD | SHS ADDED | M53644106 | $756 | 135,000 | 0.0% |
| Abeona Therapeutics Inc(ABEO1EUR) | COM | 00289Y107 | $736 | 181,818 | 0.0% |
| Arena Pharmaceuticals Inc | COM | 040047102 | $729 | 381,600 | 0.0% |
| Uniqure B.V.(QURE) | NV SHS | N90064101 | $716 | 35,000 | 0.0% |
| Cynapsus Therapeutics Inc | COM PAR NO PAR | 23257Y859 | $707 | 44,824 | 0.0% |
| Akari Therapeutics PLC | ADR ADDED | 00972G108 | $633 | 26,390 | 0.0% |
| Syneron Medical LTD | ORD SHS | M87245102 | $615 | 85,947 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $590 | 18,000 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $589 | 90,000 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $562 | 5,200 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $560 | 5,700 | 0.0% |
| Exactech Inc | COM | 30064E109 | $551 | 31,636 | 0.0% |
| Ironwood Pharma | NOTE 2.25% 15-Jun-2022 144A SR UNSECURED CONV | 46333XAC2 | $537 | $600,000 | 0.0% |